Testing Period 2019-2024

Brain Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 192,477 Patients

Breast Cancer:

Tested &Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 428,166 Patients

Colon/Rectum Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 400,728 Patients

Lung/Bronchus Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 571,206 Patients

Prostate Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 322,714 Patients

Skin Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 210,471 Patients

Testing Period 2017-2022

Brain Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 114,383 Patients

Breast Cancer:

Tested &Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 380,715 Patients

Colon/Rectum Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 276,634 Patients

Lung/Bronchus Cancer:

Tested & Treated with new medication in United Kingdom, Switzerland, Germany and Italy: 444,382 Patients